About: Control of Infectious Diseases in the Era of European Clinical Microbiology Laboratory Consolidation: New Challenges and Opportunities for the Patient and for Public Health Surveillance

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Control of Infectious Diseases in the Era of European Clinical Microbiology Laboratory Consolidation: New Challenges and Opportunities for the Patient and for Public Health Surveillance Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Control of Infectious Diseases in the Era of European Clinical Microbiology Laboratory Consolidation: New Challenges and Opportunities for the Patient and for Public Health Surveillance
Creator	Schrenzel, Jacques Breuer, Judith Vandenberg, Olivier Eremin, Sergey Kozlakidis, Zisis Struelens, Marc Abolhassani, Hassan Inglis, Tim
Source	Medline; PMC
abstract	Many new innovative diagnostic approaches have been made available during the last 10 years with major impact on patient care and public health surveillance. In parallel, to enhance the cost-effectiveness of the clinical microbiology laboratories (CMLs), European laboratory professionals have streamlined their organization leading to amalgamation of activities and restructuring of their professional relationships with clinicians and public health specialists. Through this consolidation process, an operational model has emerged that combines large centralized clinical laboratories performing most tests on one high-throughput analytical platform connected to several distal laboratories dealing locally with urgent analyses at near point of care. The centralization of diagnostic services over a large geographical region has given rise to the concept of regional-scale “microbiology laboratories network.” Although the volume-driven cost savings associated with such laboratory networks seem self-evident, the consequence(s) for the quality of patient care and infectious disease surveillance and control remain less obvious. In this article, we describe the range of opportunities that the changing landscape of CMLs in Europe can contribute toward improving the quality of patient care but also the early detection and enhanced surveillance of public health threats caused by infectious diseases. The success of this transformation of health services is reliant on the appropriate preparation in terms of staff, skills, and processes that would be inclusive of stakeholders. In addition, rigorous metrics are needed to set out more concrete laboratory service performance objectives and assess the expected benefits to society in terms of saving lives and preventing diseases.
has issue date	2018-02-02(xsd:dateTime)
bibo:doi	10.3389/fmed.2018.00015
bibo:pmid	29457001
has license	cc-by
sha1sum (hex)	6e0b5bbe1af91b80c9ac2fa22fea4d845c6230c8
schema:url	https://doi.org/10.3389/fmed.2018.00015
resource representing a document's title	Control of Infectious Diseases in the Era of European Clinical Microbiology Laboratory Consolidation: New Challenges and Opportunities for the Patient and for Public Health Surveillance
has PubMed Central identifier	PMC5801420
has PubMed identifier	29457001
schema:publication	Front Med (Lausanne)
resource representing a document's body	covid:6e0b5bbe1af91b80c9ac2fa22fea4d845c6230c8#body_text
is schema:about of	named entity 'CONSOLIDATION' named entity 'process' named entity 'point' named entity 'infectious diseases' named entity 'LABORATORY' named entity 'CHALLENGES' named entity 'ENHANCED' named entity 'PROFESSIONALS' named entity 'IMPROVING' named entity 'DIAGNOSTIC' named entity 'QUALITY' named entity 'CONCEPT' named entity 'CONSEQUENCE' named entity 'THROUGHPUT' named entity 'THREATS' named entity 'CMLS' named entity 'BENEFITS' named entity 'DRIVEN' named entity 'CONSOLIDATION' named entity 'AVAILABLE' named entity 'EUROPEAN' named entity 'LOCALLY' named entity 'PERFORMING' named entity 'COST SAVINGS' named entity 'SPECIALISTS' named entity 'POINT OF CARE' named entity 'SCALE' named entity '28S' named entity 'VOLUME' named entity 'SERVICE' named entity 'TRANSFORMATION' named entity 'SKILLS' named entity 'NETWORKS' named entity 'REGIONAL' named entity 'ACTIVITIES' named entity 'INCLUSIVE' named entity 'SELF' named entity 'HIGH' named entity 'APPROACHES' named entity 'YEARS' named entity 'CLINICAL LABORATORIES' named entity 'LANDSCAPE' named entity 'INFECTIOUS DISEASE SURVEILLANCE' named entity 'CONTRIBUTE ' named entity 'MAJOR' named entity 'RANGE' named entity 'NEW' named entity 'SURVEILLANCE' named entity 'PREPARATION' named entity 'PUBLIC HEALTH' named entity 'PROFESSIONAL' named entity 'OPERATIONAL MODEL' named entity 'ARTICLE' named entity 'HAVE' named entity 'LIVES' named entity 'DESCRIBE' named entity 'METRICS' named entity 'THEIR' named entity 'EXPECTED' named entity 'HEALTH SERVICES' named entity 'CONTROL' named entity 'ERA' named entity 'INFECTIOUS DISEASES' named entity 'PATIENT' named entity 'EUROPEAN' named entity 'ADDITION' named entity 'NEAR' named entity 'CAUSED BY' named entity 'RISE' named entity 'CLINICAL MICROBIOLOGY' named entity 'PARALLEL' named entity 'LEADING' named entity 'PATIENT CARE' named entity 'OBJECTIVES'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software